Quantcast

Elsevier and Molecular Connections Develop Two New Applications on SciVerse Applications

June 16, 2011

AMSTERDAM, June 16, 2011 /PRNewswire/ –

                -- "Ask Extractor" and "Journal Trends" Help Researchers
                              Narrow Search Results --

Elsevier, a world-leading provider of scientific, technical and medical
information products and services, today announced two new applications from
Molecular Connections, a life science informatics company, on SciVerse
Applications beta [http://www.applications.sciverse.com ].

Ask Extractor is an application based on Molecular Connections XTractor,
a platform for discovery, analysis and modelling of biomedical information.
The application provides search suggestions for life sciences terms entered
into SciVerse Hub [http://www.hub.sciverse.com ] and SciVerse ScienceDirect
[http://www.sciencedirect.com ]. The second application, Journal Trends,
enables users to discover top journals as a result of a given search query.

“Due to the enormous amount of published scientific information,
applications that refine and simplify search results, or assist in creating
a targeted query, can significantly benefit researcher workflows,” said
Vidyendra Sadanand, Chief Technology Officer of Molecular Connections.

“Molecular Connections has significant expertise in providing solutions
to the life science research community,” said Rafael Sidi, Vice President,
Application Marketplace and Developer Network at Elsevier. “We look forward
to continuing our work with Molecular Connections and the developer
community to deliver applications that will improve researchers’
productivity.”

SciVerse Applications [http://www.applications.sciverse.com ] and the
Developer Network [http://developers.sciverse.com ] provide opportunities for
researchers and librarians to collaborate with developers in creating and
promoting new applications that improve research workflows. The Developer
Network features a growing community of application developers that gain
potential recognition, prestige and revenue through their contributions to
SciVerse Applications.

About Molecular Connections

Molecular Connections (http://www.molecularconnections.com) is a
pioneering In silico Discovery Services Company. It provides high quality,
cost effective curation, literature informatics solutions and annotation
services as well as products. Customers of Molecular Connections include
leading pharmaceutical and biotechnology, drug discovery, genomics,
proteomics, medical technology, equipment companies and academic
institutions spanning across the globe. In addition, Molecular Connections
has powerful tool development, database integration, effective data
visualization capabilities, specific expertise in building knowledge bases
for rapidly growing needs in, ADME Tox, clinical, drugs, chemistry and
patent industries. For more information write to Krishna Chinnaia at
krishna@molecularconnections.com.

About the Elsevier SciVerse Suite

The SciVerse (http://www.sciverse.com)suite of search and discovery
offerings provides the global research community access to a constantly
expanding universe of content and solutions which can now be accessed in one
platform. The suite currently includes SciVerse ScienceDirect
(http://www.sciencedirect.com), the world’s largest source of
peer-reviewed content containing more than 10 million articles, and SciVerse
Scopus (http://www.scopus.com), an abstract and citation database containing
41 million records, 70% with abstracts and nearly 18,000 titles from 5,000
publishers worldwide. The platform also includes SciVerse Hub beta
(http://www.hub.sciverse.com), which enables researchers to perform a single
search across all of the SciVerse content as well as targeted web content
with results ranked by relevancy and without duplication. SciVerse
Applications (http://www.applications.sciverse.com) and Developer Network
(http://www.developers.sciverse.com) allow the scientific community to
build, find and use applications that enhance the SciVerse research
experience.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (http://www.thelancet.com) and Cell
(http://www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
SciVerse ScienceDirect (http://www.sciencedirect.com), SciVerse Scopus
(http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult
(http://www.mdconsult.com) and Nursing Consult (
http://www.nursingconsult.com), which enhance the productivity of science
and health professionals, and the SciVal suite (http://www.scival.com) and
MEDai’s Pinpoint Review (http://www.medai.com), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
http://www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact

        Sandra Plasse
        splasse@psbpr.com
        +1-212-752-8338

SOURCE Elsevier


Source: newswire



comments powered by Disqus